255 related articles for article (PubMed ID: 32921715)
1. Cardiovascular system is at higher risk of affecting by COVID-19.
Nejadghaderi SA; Heidari A; Shakerian N; Saghazadeh A; Rezaei N
Acta Biomed; 2020 Sep; 91(3):e2020018. PubMed ID: 32921715
[TBL] [Abstract][Full Text] [Related]
2. Covid-19 and cardiovascular risk: Susceptibility to infection to SARS-CoV-2, severity and prognosis of Covid-19 and blockade of the renin-angiotensin-aldosterone system. An evidence-based viewpoint.
Cappuccio FP; Siani A
Nutr Metab Cardiovasc Dis; 2020 Jul; 30(8):1227-1235. PubMed ID: 32595085
[TBL] [Abstract][Full Text] [Related]
3. [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus].
Verdecchia P; Reboldi G; Cavallini C; Mazzotta G; Angeli F
G Ital Cardiol (Rome); 2020 May; 21(5):321-327. PubMed ID: 32310915
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular disease and the impact of COVID-19.
Yoganathan A; Sajjad MS; Harky A
J Card Surg; 2020 Aug; 35(8):2113. PubMed ID: 32542799
[No Abstract] [Full Text] [Related]
5. Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study.
Yang G; Tan Z; Zhou L; Yang M; Peng L; Liu J; Cai J; Yang R; Han J; Huang Y; He S
Hypertension; 2020 Jul; 76(1):51-58. PubMed ID: 32348166
[TBL] [Abstract][Full Text] [Related]
6. COVID-19: a conundrum to decipher.
Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
[TBL] [Abstract][Full Text] [Related]
7. Do underlying cardiovascular diseases have any impact on hospitalised patients with COVID-19?
Zhang J; Lu S; Wang X; Jia X; Li J; Lei H; Liu Z; Liao F; Ji M; Lv X; Kang J; Tian S; Ma J; Wu D; Gong Y; Xu Y; Dong W
Heart; 2020 Aug; 106(15):1148-1153. PubMed ID: 32451362
[TBL] [Abstract][Full Text] [Related]
8. Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities.
Wang JJ; Edin ML; Zeldin DC; Li C; Wang DW; Chen C
Pharmacol Ther; 2020 Nov; 215():107628. PubMed ID: 32653530
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility and prognosis of COVID-19 patients with cardiovascular disease.
Wang BX
Open Heart; 2020 Jun; 7(1):. PubMed ID: 32587104
[No Abstract] [Full Text] [Related]
10. Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19.
Kow CS; Zaidi STR; Hasan SS
Am J Cardiovasc Drugs; 2020 Jun; 20(3):217-221. PubMed ID: 32281055
[TBL] [Abstract][Full Text] [Related]
11. Considerations on the use of antihypertensive blockers of the renin-angiotensin system in adults and children in the face of the COVID-19 pandemic.
Vázquez-Cornejo E
Bol Med Hosp Infant Mex; 2020; 77(5):274-281. PubMed ID: 33064690
[TBL] [Abstract][Full Text] [Related]
12. Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era.
Ceriello A; Standl E; Catrinoiu D; Itzhak B; Lalic NM; Rahelic D; Schnell O; Škrha J; Valensi P;
Diabetes Care; 2020 Jul; 43(7):1427-1432. PubMed ID: 32409501
[TBL] [Abstract][Full Text] [Related]
13. Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19.
Diaz JH
J Travel Med; 2020 May; 27(3):. PubMed ID: 32186711
[TBL] [Abstract][Full Text] [Related]
14. Renin-Angiotensin-Aldosterone System Inhibitors Impact on COVID-19 Mortality: What's Next for ACE2?
Patel AB; Verma A
Clin Infect Dis; 2020 Nov; 71(16):2129-2131. PubMed ID: 32442259
[No Abstract] [Full Text] [Related]
15. Cardiovascular molecular mechanisms of disease with COVID-19.
Foo R; Wang Y; Zimmermann WH; Backs J; Wang DW
J Mol Cell Cardiol; 2020 Apr; 141():107. PubMed ID: 32289321
[No Abstract] [Full Text] [Related]
16. Two hits to the renin-angiotensin system may play a key role in severe COVID-19.
Tseng YH; Yang RC; Lu TS
Kaohsiung J Med Sci; 2020 Jun; 36(6):389-392. PubMed ID: 32492292
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 and the Heart.
Rojulpote C; Gonuguntla K; Patil S; Bhattaru A; Bravo PE
Colomb Med (Cali); 2020 Jun; 51(2):e4320. PubMed ID: 33012891
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of SARS-CoV-2 infection in patients with intracerebral hemorrhage.
Dong S; Liu P; Luo Y; Cui Y; Song L; Chen Y
Aging (Albany NY); 2020 Jul; 12(13):13791-13802. PubMed ID: 32633728
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 and Cardiovascular diseases. Scoping review study.
Yahia F; Zakhama L; Ben Abdelaziz A
Tunis Med; 2020 Apr; 98(4):283-294. PubMed ID: 32395790
[TBL] [Abstract][Full Text] [Related]
20. MAFLD in COVID-19 patients: an insidious enemy.
Dongiovanni P; Meroni M; Longo M; Fracanzani AL
Expert Rev Gastroenterol Hepatol; 2020 Oct; 14(10):867-872. PubMed ID: 32705906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
